Superior Trunk Block Applied for Upper Arm Surgery
Investigation of the Effectiveness of Superior Trunk Block Applied for Upper Arm Surgery Operation Analgesia
1 other identifier
interventional
60
1 country
1
Brief Summary
Nerve blocks applied with ultrasonography are currently used for many post-operative pain and operations. Providing adequate area analgesia is the primary goal of clinicians, as early mobilization is suggested after shoulder and arm surgery. In this study aimed to investigate the effect of superior trunk block application on postoperative analgesic and motor functions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2022
CompletedStudy Start
First participant enrolled
July 20, 2022
CompletedFirst Posted
Study publicly available on registry
July 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedJanuary 25, 2024
January 1, 2024
1.3 years
July 19, 2022
January 24, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Visual Analog Scale
Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS). (0=no pain, 10=intolerable pain)
Postoperative 24 hours
Secondary Outcomes (4)
tramadol consumption amount
Postoperative 24 hours
additional analgesic use amount
Postoperative 24 hours
postoperative complications
Postoperative 24 hours
Horner syndrome
Postoperative 24 hours
Study Arms (2)
superior trunk block
ACTIVE COMPARATORUltrasound guided superior trunk block with 10 ml % 0.25 bupivacaine \+ 400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.
tramadol
ACTIVE COMPARATOR400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.
Interventions
Local anesthetic injection will be applied to the superior trunk of the brachial plexus accompanied by ultrasonography.
Analgesics will be given using a patient-controlled analgesia device.
Eligibility Criteria
You may qualify if:
- Patients who were in the American Society of Anesthesiologists (ASA) I-III class
- Underwent upper arm surgery
You may not qualify if:
- Previous local anesthetic allergy,
- Having a bleeding diathesis disorder,
- Mental disorder,
- Allergic to the drugs used,
- Patients who did not consent to participate in the study,
- Presence of infection in the block area,
- Patients with a body mass index above 30
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bursa Yuksek Ihtisas Training and Research Hospital
Bursa, 16110, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Korgün Ökmen, Assoc. PhD.
Sağlık Bilimleri Üniversitesi Bursa Yüksek İhtisas Eğitim Ve Araştırma Hastanesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc.Phd.M.D
Study Record Dates
First Submitted
July 19, 2022
First Posted
July 26, 2022
Study Start
July 20, 2022
Primary Completion
November 1, 2023
Study Completion
December 1, 2023
Last Updated
January 25, 2024
Record last verified: 2024-01